Clare Market Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,849
| Closed | -$310K | – | 134 |
|
|
2023
Q2 | $310K | Sell |
4,849
-592
| -11% | -$37.9K | 0.12% | 97 |
|
|
2023
Q1 | $377K | Sell |
5,441
-3,243
| -37% | -$225K | 0.16% | 77 |
|
|
2022
Q4 | $625K | Sell |
8,684
-9,885
| -53% | -$711K | 0.29% | 49 |
|
|
2022
Q3 | $1.32M | Sell |
18,569
-2,899
| -14% | -$206K | 0.57% | 23 |
|
|
2022
Q2 | $1.65M | Buy |
21,468
+9,234
| +75% | +$711K | 0.72% | 18 |
|
|
2022
Q1 | $893K | Buy |
12,234
+8,668
| +243% | +$633K | 0.28% | 51 |
|
|
2021
Q4 | $222K | Sell |
3,566
-1,354
| -28% | -$84.4K | 0.06% | 137 |
|
|
2021
Q3 | $291K | Sell |
4,920
-295
| -6% | -$17.5K | 0.09% | 110 |
|
|
2021
Q2 | $349K | Sell |
5,215
-1,751
| -25% | -$117K | 0.11% | 96 |
|
|
2021
Q1 | $440K | Sell |
6,966
-60
| -0.9% | -$3.79K | 0.17% | 70 |
|
|
2020
Q4 | $436K | Sell |
7,026
-4,004
| -36% | -$248K | 0.18% | 68 |
|
|
2020
Q3 | $665K | Sell |
11,030
-813
| -7% | -$49K | 0.33% | 49 |
|
|
2020
Q2 | $696K | Buy |
11,843
+534
| +5% | +$31.4K | 0.41% | 40 |
|
|
2020
Q1 | $631K | Buy |
11,309
+1,735
| +18% | +$96.7K | 0.53% | 30 |
|
|
2019
Q4 | $615K | Buy |
9,574
+4,579
| +92% | +$294K | 0.44% | 47 |
|
|
2019
Q3 | $253K | Sell |
4,995
-929
| -16% | -$47.1K | 0.24% | 64 |
|
|
2019
Q2 | $269K | Sell |
5,924
-760
| -11% | -$34.5K | 0.21% | 78 |
|
|
2019
Q1 | $319K | Buy |
6,684
+1,744
| +35% | +$83.2K | 0.28% | 75 |
|
|
2018
Q4 | $257K | Buy |
+4,940
| New | +$257K | 0.33% | 58 |
|